S. Todorović, “RISK OF COVID-19 INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH OCRELIZUMAB – A SINGLE CENTER EXPERIENCE”, АММ, vol. 62, no. 3, Nov. 2023, Accessed: Sep. 20, 2026. [Online]. Available: https://test.aseestant.ceon.rs/index.php/amm/article/view/41552